• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding

    The Baseline

    12
    Following
    368
    Stocks Tracked
    49
    Sectors & Interests
    Follow
    Load latest
    logo
    The Baseline
    04 Mar 2025
    Five stocks to buy from analysts this week - March 04, 2025

    Five stocks to buy from analysts this week - March 04, 2025

    By Divyansh Pokharna

    1. SRF:

    Emkay reiterates its ‘Buy’ rating on this specialty chemicals firm with a target price of Rs 3,250. This indicates a potential upside of 13.9%. SRF is experiencing strong demand and higher prices for refrigerant gases in India. Globally, prices of R32 and R22, commonly used in air conditioning and cooling, are rising due to higher refrigerant gas prices in China and a shift to eco-friendly alternatives with lower global warming impact. Analysts Meet Vora and Meet Gada expect prices to remain stable through this season and into 2025. 

    Vora and Gada noted the company’s efforts to reduce costs for key products while keeping profit margins steady (EBITDA margin at 19.7% in FY24). SRF’s new active ingredients (AIs) are expected to start making a significant impact from FY26 and reach full production by FY28. The total market for manufacturing these AIs is estimated at around $1-1.5 billion, with SRF aiming to capture a 35-40% share.

    The analysts project SRF’s revenue to grow at a CAGR of 17.6% and net profit at 52% over FY25-27. This growth is expected to be driven by increasing contributions from new products, and rising refrigerant gas prices globally.

    2. Godrej Properties:

    Hem Securities initiates a ‘Buy’ rating on this Mumbai-based realty company with a target price of Rs 2,405. This indicates a potential upside of 19.8%. The company’s revenue grew 126% YoY to Rs 1,240 crore in Q3FY25, driven by the delivery of 2.6 million square feet (msf) of projects.

    Analyst Deepanshu Jain highlights that the company has achieved 71% of its Rs 27,000 crore FY25 booking value target. Godrej Properties has surpassed its business development guidance of Rs 20,000 crore, adding 16.9 msf of saleable area with a potential booking value of Rs 23,450 crore. 

    Management remains confident in achieving its Rs 30,000 crore launch target, supported by Rs 7,000 crore in Q4 launches across Hyderabad, Noida, Gurugram, Mumbai, Pune, and Indore. The company also raised Rs 6,000 crore through a qualified institutional placement (QIP) to expand its project pipeline.

    Jain is optimistic about the company, citing its CY24 pre-sales of Rs 2.9 lakh crore as the highest among peers. With better cash flow, a strong land bank, and high demand, he expects sales to grow at 39.8% CAGR and net profit at 31.4% over FY25-26.

    3. AU Small Finance Bank:

    ICICI Securities upgrades its rating to ‘Buy’ on this bank with a target price of Rs 725, indicating a potential upside of 32.2%. AU Small Finance Bank (AU SFB) merged with Fincare Small Finance Bank in April 2024. Following the merger, AU SFB’s profitability was affected by higher-than-expected loan defaults in its credit card (CC) and microfinance (MFI) portfolios, leading to increased credit costs. For 9MFY25, credit costs stood at 5.4% in the MFI segment and 9.2% in the CC segment. 

    AU SFB’s return on assets (RoA) fell to 1.5% in Q3, reflecting a continued pressure on profitability. Analysts Renish Bhuva and Chintan Shah expect RoA to gradually improve to ~1.8% by FY27, driven mainly by a reduction in credit costs, which are projected to normalize to 3% in the MFI segment and 6–7% in the credit card segment.

    Bhuva and Shah are optimistic about the RBI’s 25 bps rate cut to 6.25%, believing that the bank is well-positioned to benefit the most in the current falling rate cycle. They point out that during the last rate-cut cycle, the repo rate dropped from 6.5% in December 2018 to 4% in May 2020. Within a year of the cut, AU SFB’s margins expanded by 100–120 bps.

    The bank’s management has raised its net interest margin (NIM) estimate to 6% for FY25, up from its earlier guidance of 5.8% in H1 FY25, while analysts expect it to be slightly higher at 6.2%.

    4. Krishna Institute of Medical Sciences:

    Geojit BNP Paribas upgrades its rating to ‘Buy’ on this hospitals company with a target price of Rs 622, indicating an upside of 21.3%. In Q3FY25, the company’s revenue grew 27.5% YoY to Rs 772 crore, while average revenue per operating bed (ARPOB) increased by 25.2%. However, occupancy declined to 50.7% from 61.6% in Q3 FY24, mainly due to lower occupancy at its Telangana facilities. 

    Krishna Institute of Medical Sciences (KIMS) recently signed an agreement with Valiyath Institute of Medical Sciences (VIMS) in Kerala’s Kollam district to manage its 300-bed facility. It also plans to expand capacity over the next two years, including in Telangana and Andhra Pradesh. The company has allocated Rs 500-600 crore for expansion in the coming year.

    The analysts highlight that with new units set to contribute, KIMS is well-positioned to achieve its FY25 revenue growth target of 24% and continue expanding beyond that. They project revenue and profit CAGR of 28% and 32%, respectively, over FY25-27.

    5. Healthcare Global Enterprises:

    Axis Direct maintains a ‘Buy’ rating on this cancer care hospitals company with a target price of Rs 575, indicating an upside potential of 12.1%. In Q3FY25, revenue rose 18.9% YoY to Rs 1,058.7 crore, driven by a 3.5% YoY increase in average revenue per occupied bed (ARPOB) and 16% growth in occupied days. 

    Analysts Ankush Mahajan and Aman Goyal note that during the quarter, the company acquired MG Hospital in Vizag, which contributed Rs 25 crore in revenue with EBITDA margins of 24%. The company’s digital business grew by 14% YoY, generating Rs 76 crore in revenue. Meanwhile, KKR, an American private-equity and investment firm, acquired a majority stake 54% in Healthcare Global for approximately Rs 3,350 crore, taking full control from CVC Asia.

    Mahajan and Goyal stated that the company operates in the cancer treatment industry, which is expanding at 17% CAGR. To capitalize on the emerging opportunities the company plans to add 900 beds over the next 4-5 years. Management expects EBITDA margins to expand by 100-150 bps in FY26. The analysts also anticipate a 1,000 bps increase in return on invested capital (RoIC) over the next three years.

    Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

    (You can find all analyst picks here)

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    28 Feb 2025
    Five Interesting Stocks Today - February 28, 2025

    Five Interesting Stocks Today - February 28, 2025

    By Trendlyne Analysis

    1. Ultratech Cement:

    This cement & cement products company fell 6.2% since Thursday despite announcing its foray into the wires and cables (W&C) segment, investing Rs 1,800 crore to set up a plant in Gujarat over the next two years. 

    The stock plunged after analysts at Citi Research said the expansion would hurt Ultratech’s positioning as a pure-play cement company. Other analysts at JM Financial, Axis Capital, and Jefferies noted that the firm’s investment in a non-cement business might raise doubts among investors about capital allocation. 

    The company’s board of directors also approved the demerger of the cement business from its subsidiary, Kesoram Industries. As per the demerger agreement, shareholders of Kesoram Industries will get one share of the demerged entity for every 52 shares held in the company.

    The board aims to meet the growing demand for wires and cables across residential, commercial, infrastructure, and industrial sectors. The wires and cables industry grew at a CAGR of 13% from FY19-24. 

    CLSA expects the new segment to drive 4x- 5x revenue growth with 11-13% margins. However, the brokerage expects rising competition in the wires and cables segment may hurt sector profitability. It also expects UltraTech to prioritize wires over cables in its new venture. 

    Speaking on the expansion plans, Ultratech Cement’s Chairman, Kumar Mangalam Birla said, “We intend to expand our presence in the construction value chain through our foray in the cables and wires segment, which aligns with our vision of providing comprehensive solutions to our end customers in the construction sector.”

    The company’s expansion news came as a disaster for the cables & wires industry, with Polycab India, KEI Industries, R R Kabel, and Havells India plunging 18.8%, 21%, 19.8%, and 6.2%, respectively, on Thursday. These stocks fell after expectations of de-rating and margin pressure from investors.

    2. Blue Star:

    This air conditioner manufacturer's stock rose 2.5% on February 27 after it announced the commissioning of a new assembly line for room air conditioners (AC) at its Sri City plant in Andhra Pradesh. The company has allocated Rs 200 crore for the project, expanding its capacity by 20,000 units per month.

    Blue Star’s Sri City facility is operating at full capacity with 6.5 lakh units and will expand to 12 lakh units by FY27. The company aims for a 13.8% market share by FY25 and 14.3% in FY26. Its 15% target, initially set for FY25, has been pushed to FY27.

    Managing Director B. Thiagarajan said, "We aim to maintain an 8.5% operating margin while working towards a 15% market share. The original equipment manufacturers (OEMs) are increasing their production capacity, which should help stabilize supply and demand." He also mentioned that the room AC market is expected to grow by 20-25% with a promising summer ahead.

    In Q3FY25, Blue Star’s revenue grew 20% YoY, driven by outperformance in the electro-mechanical projects and commercial AC segment. Net profit rose 36% YoY, driven by lower finance costs and inventory destocking. Both revenue and net profit beat Forecaster estimates by 4% and 5%, respectively.

    Over the past quarter, foreign investors increased their holdings from 18.1% to 18.5%, while mutual funds reduced their stake from 20.8% to 20.1%. However, mutual funds have shown renewed interest, as the stock appears in a screener of companies where they increased holdings in the last month.

    Jefferies downgraded Blue Star to 'Hold', citing limited upside potential after the stock surged 140% in CY24. However, the brokerage noted that demand for ACs and cooling products in Q4FY25 is expected to exceed 25%.

    3. Havells India:

    This electrical equipment company fell 6.2% to a new 52-week low of Rs 1,402.2 on Thursday, following UltraTech Cement's announcement of its entry into the wires and cables segment, with a Rs 1,800 crore investment over the next two years. This development is expected to intensify competition and lead to pricing pressures in the industry, impacting companies like Havells India, Polycab India, and KEI Industries.

    In Q3FY25, Havells' net profit fell 3.3% YoY to Rs 278.3 crore as its EBITDA margin contracted 100bps YoY to 8.8%. However, revenue grew 10.8% YoY to Rs 4,889 crore, driven by the wires and cables segment, which rose 7% YoY to Rs 1,690 crore. This segment contributes 35% to the total revenue. 

    The lighting segment faced challenges due to price cuts owing to competitive pressure from brands like Philips, which impacted the margins. Havells’ Lloyd division, acquired in 2017 for Rs 1,600 crore, still remains unprofitable. Although performance improves during peak seasons, the division has not yet achieved full-year breakeven.

    Havells India plans to enter the electric vehicle (EV) charging market within the next six months. Vivek Yadav, Executive Vice President of the company,stated, “The EV scene in India is set to grow multi-fold. We identified chargers as a key business, as the charging infrastructure in India is still nascent.” The company intends to start with a business-to-business focus on automakers before expanding into the retail market.

    Additionally, Havells is investing in internet-connected household devices, enhancing its Internet of Things (IoT) capabilities, which enables consumers to monitor and optimize their energy consumption efficiently. Yadav noted that the company allocates over 2% of its turnover to research and development.

    Motilal Oswal maintains its ‘Neutral’ rating on the company, highlighting that while revenue growth in Q3FY25 was driven by improved consumer demand, lower margins in the switchgear segment and higher losses in the Lloyd division weighed on earnings. The brokerage expects revenue, EBITDA, and net profit to grow at a CAGR of 14%, 21%, and 23% over FY25-27.

    4. Chalet Hotels:

    Thishotel company’s share price rose 3.6% over the past week afterICICI Securities increasedthe target price to Rs 1,017 (from Rs 965 earlier) while retaining its ‘Buy’ call. Chalet Hotels recentlyacquired Mahananda Spa and Resorts in an all-cash deal worth Rs 530 crore. 

    This deal adds the Westin Resort & Spa to Chalet Hotels' portfolio. The acquired hotel has 141 rooms, with an expected average room rate of Rs 25,000-30,000 per night. The resort has 45% occupancy and is expected to reach 60% within a year. With the addition of these 141 rooms, the company will have around 3,200. It aims to reach around 5,000 rooms over the next two quarters. 

    Chalet Hotels’ revenue grew 21.9% YoY to Rs 457.8 crore inQ3FY25, beatingTrendlyne’s Forecaster estimates by 0.6%. Improvements in the hospitality and rental segments drove growth. Meanwhile, net profit increased 36.7% YoY to Rs 96.5 crore.

    During thequarter, the company’s hospitality revenue grew 17% YoY. Chalet Hotels’ revenue per available room (RevPAR) increased 16% to Rs 9,090, while its occupancy reached 70%. The management is optimistic that the company will achieve double-digit RevPAR in FY25. 

    Commenting on the future outlook, Managing Director and CEO Sanjay Sethisaid, “Q4 is always better than Q3, and we expect this trend to continue in the coming quarters. For Q1FY26, we see weddings contributing to demand, which was not the case last year, providing an upside. Additionally, we expect corporate travel to remain strong in the coming months.”

    ICICI Securities believes the recent acquisition strengthens growth prospects while its expansion plans are on track. The brokerage is optimistic about Chalet's growth, citing its rental expansion, hotel developments, and upcoming projects like the Taj Hotel at Delhi Airport T3, Hyatt Regency Navi Mumbai, and CIGNUS POWAI Tower II. Analysts expect strong industry demand driven by leisure and business travel. The changing preference for branded hotels, a shift of weddings to hotels, and growth in destination weddings also bode well for the hotel operator.

    5. Bharti Airtel:

    Thistelecom company surged 2.5% on Wednesday following theannouncement of ongoing discussions to merge the Tata Group’s DTH business with its own. This deal is reportedly expected to be structured as a share swap, with Airtel acquiring a majority stake and existing Tata Play shareholders retaining a 45-48% stake in the combined entity.

    InQ3, the firm reported revenue growth of 19%, and its net profit surged six times YoY. Both revenue and net profit exceeded Forecaster estimates. The surge in net profit was due to the consolidation of Indus Towers and a lower tax rate. Average revenue per user (ARPU) grew 18% YoY to Rs 245, driven by tariff hikes, and net subscriber addition stood at around 5 million, 50% higher than that of Jio.

    Mobile services, whichcontribute most of its revenue, surged 21% YoY as subscribers transitioned from 2G to 4G. Postpaid subscriber growth of 13% YoY and rising ARPU added to the revenue surge. VC and MD Gopal Vittal believes that 80 million subscribers can potentially upgrade to Airtel’s postpaid services, further adding to the growth momentum.

    Bharti Airtel incurred 5% lower capex of Rs 7,400 crore in Q3 compared to the same period last year. Vittalsaid, “We are not putting any investments in 4G capacity; all we are doing is a few more 5G radios as we expand and see more devices coming in.” He expects capex to decline this year and further reduce in FY26.

    ICICI Securitiesmaintains a ‘Buy’ rating on the stock as it expects Bharti to increase its market share further and narrow its gap with Jio. They also believe that disciplined capital allocation and tight control on capex will improve EBITDA margins by 410bps in FY26. With a target price of Rs 1,925, Bharti Airtel has a potential upside of 22.6%.

    Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    26 Feb 2025
    Nifty Midcap is the winner among indices. But it's not without risks | Screener: Stocks that outperformed Q3, with strong estimates for next quarter

    Nifty Midcap is the winner among indices. But it's not without risks | Screener: Stocks that outperformed Q3, with strong estimates for next quarter

    By Tejas MD

    The Indian stock market has been caught in a bear hug. The Nifty 50 is set to post losses for the fifth straight month—a trend we haven't seen since 1996. Unlike previous sharp corrections though, this downturn has been a slow bleed, with red ink drip-dripping across the charts every month.

    Just six months ago, the mood was very different. Markets were hitting record highs. It seemed like stocks could only go up.

    A mix of heavy FII selling, earnings downgrades, and global uncertainty, especially from the US, sent the market into reverse. If you poured in money during the highs, well, let’s just say that it hasn’t been the most rewarding stretch.

    As the joke goes, "Everyone becomes a long-term investor in a falling market."

    So with this extended correction, have valuations finally become attractive, or are stocks still overpriced?

    To get a clearer picture, we turned to Trendlyne’s Historical PE Analysis tool to see where things stand for the Nifty 50, Nifty Midcap 100, and Nifty Smallcap 100.

    Let’s dive in.

    In this week’s Analyticks, 

    • Valuation check: The benchmark Nifty 50 index turns attractive 
    • Screener: Stocks which beat Q3 Forecaster estimates for revenue and net profit with high revenue and EPS growth expectations for Q4FY25

    Nifty Midcap 100 wins in the long run, but there are risks

    The recent market correction has dragged the major indices down from their peaks. The Nifty 50 and Nifty Midcap 100 have entered the correction zone after falling over 10% from their highs, and the Nifty Smallcap 100 has crossed the 20% loss mark (bear market territory). 

    Nifty Midcap 100 outperforms peers in long term gains

    Despite these short-term setbacks, the Nifty Midcap 100 has proven its strength over the long run, outperforming both the Nifty 50 and the Nifty Smallcap 100. But this impressive performance comes with heightened valuation risks.

    Sankaran Naren, Chief Investment Officer of ICICI Prudential Mutual Fund, said in an event on February 12, “India has one of the best macros in the world compared to other countries, but our smallcap and midcap valuations are absolutely absurd right now”. He asked investors to pause their SIP in the current environment.  

    However on Monday, Citigroup upgraded its rating on Indian stocks from ‘neutral’ to ‘overweight’, pointing to improving consumer sentiment, expected rate cuts, and minimal exposure to US trade risk.

    Midcaps shine, but earnings struggle

    The Nifty Midcap 100 has historically commanded a higher price-to-earnings (PE) ratio, due to the stronger growth potential of its companies, which are seen as mid-sized and fast-growing. At 33.9, it has the highest PE among the three major indices.

    But this elevated PE is also due to a sharp drop in its earnings per share (EPS) in Q4FY24.

    Nifty 50 PE falls 12.2% in the past year, while Nifty Midcap 100 PE surges 33.2%

    The Q3FY25 results did not help the Nifty Midcap’s EPS recover to the March 2024 level. Companies like Oil India (Oil and gas), Petronet LNG (Oil and gas), and Oracle Financial Services (Software and services) reported sharp falls in their EPS. As a result, the Nifty Midcap continues to trade at a high PE.

    Analysts see Nifty 50 as the most promising, backed by historical data

    Like the Nifty Midcap, the Nifty Smallcap 100 is also trading at a premium compared to its 10-year average. Nifty Midcap 100 and Smallcap 100 both beat the Nifty 50 in revenue growth - they posted a Q3FY25 revenue growth of 8.2% and 8.7%, outpacing Nifty 50’s 4.5% increase. 

    But indices with high PE ratios are more vulnerable to market downturns, as seen in the past quarter. The Nifty Midcap 100 and Nifty Smallcap 100 both suffered steeper losses than the Nifty 50.

    In comparison, the Nifty 50 appears more reasonably valued. Its current PE is below its historical averages, and its forward PE of 19 makes it even more appealing.

    Buy zone?: 1 year forward PE of indices below current PE

    Beating the bears: Midcaps dominate the list of top performers

    The top-performing midcap companies have held on to their gains over the past year, even as the broader market has faced turbulence.

    In contrast, smallcap stocks have taken a big hit since the correction began, wiping out the triple-digit returns that once dominated the Nifty Smallcap 100. This has especially hurt large investors who specialize in smallcaps, like Ashish Kacholia.

    Top performers in Nifty Midcap 100 outperform large and Smallcap cos

    Midcaps have emerged as clear winners, with all the top five stock market performers in the Nifty Midcap 100. In the Nifty 50, the auto sector has stood out, with Mahindra & Mahindra and Eicher Motors securing two of the top five spots. 

    Foreign institutional investors (FIIs) have been selective in their bets. Only five companies across the three indices saw FII holdings increase by over 3% in Q3FY25: IDFC First Bank, Voltas, BSE, PNB Housing, CDSL, and Chambal Fertilisers. And none of these companies are in the Nifty 50.

    Worst-performing stocks: some investors are feeling the pain

    The Nifty Smallcap 100 has struggled in the past year, with only 43% of its stocks delivering gains. The Nifty Midcap 100 and Nifty 50 have fared slightly better, with 53% and 50% winner-to-loser ratios, respectively.

    Four companies across the three indices have lost nearly half their value. Hopefully, none of your portfolio picks are on this list—Mangalore Refineries (falling profits), Vodafone Idea (loss-making), Sterling and Wilson (PE of 234), Tanla Platforms (falling profits) and Sonata Software(falling margins).

    Five companies in the Nifty Smallcap 100 lose nearly half their value in the past year

    In the Nifty 50, Adani Enterprises takes the unwanted top spot as the worst performer, shedding a third of its value over the past year.

    The market correction has affected all the major indices. While midcaps have outperformed over the long term, their high valuations and recent earnings struggles raise concerns. Large caps appear more reasonably valued and could offer a safer bet amid market uncertainty. 

    But foreign brokerages like Citi and Jefferies are turning bullish on Indian markets, citing Nifty 50's attractive valuation at 19x forward earnings, which is below its historical averages.

    Looking ahead, factors like good Q4 earnings, rate cuts and FII interest could provide some support. But the red flags of elevated valuations in mid and small-cap stocks are still there. 


    Screener: Stocks which beat Q3 Forecaster estimates for revenue and net profit with high revenue and EPS growth expectations for Q4FY25

    Stocks beating Forecaster estimates are from diverse sectors

    With the end of the Q3FY25 results season, we look at stocks that outperformed expectations during the quarter, that also have high growth estimates for Q4FY25. This screener shows stocks which beat Trendlyne's Forecaster estimates for revenue and net profit in Q3FY25, with high revenue and EPS YoY growth expectations for Q4FY25.

    The screener consists of stocks from the aerospace & defence, cement & cement products, commercial vehicles, consumer electronics, IT consulting & software, and pharmaceuticals industries. Interesting stocks in the screener are Bharat Electronics, Ambuja Cements, Indian Hotels Company, Ashok Leyland, Blue Star, APL Apollo Tubes, Bajaj Finance, and Bharti Airtel.

    Bharat Electronics features in the screener after beating Forecaster estimates for revenue and net profit by 17.4% and 37.3%, respectively, in Q3FY25. This aerospace & defence stock’s revenue and net profit grew 37.6% YoY and 52.5% YoY, respectively. Revenue growth was supported by a strong order book of Rs 71,100 crore and an order inflow of Rs 11,000 crore during 9MFY25.

    Analysts at Motilal Oswal expect the company’s revenue to surge on the back of large-sized order inflows from quick reaction surface-to-air missile (QRSAM) and next-generation corvettes. However, the focus will shift to order execution. Any delays can hurt the company’s top and bottom line. 

    Indian Hotels’ Q3FY25 revenue and net profit beat forecaster estimates by 4.3% and 1.1%, respectively. This hotels stock’s revenue increased by 29.4% YoY, driven by an improvement in the food & beverage and new business segments, rising average room rate (ARR), and occupancy.

    Its net profit jumped by 28.9% YoY, led by improving margins in the new business segment and a recovery in US subsidiaries. Axis Direct expects the company’s revenue and net profit to grow on the back of a low supply of rooms and an increase in Foreign Tourist Arrivals (FTAs), which positively impact ARRs.

    You can find more screeners here.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    26 Feb 2025

    Chart of the Week: FIIs hit the brakes, shift into reverse

    By Abdullah Shah

    2024 witnessed a slew of global conflicts, sticky inflation, and high interest rates, resulting in Foreign Institutional Investors (FIIs) getting a lot pickier with their investments in the Indian equity market. Investments and withdrawals were sector-specific investments and withdrawals. 

    The trend persists in 2025 as Trump has been known to make both friends and enemies easily, and he brings this penchant into geopolitics. Markets have reacted sharply to his tariffs against allies and his outreach to Putin. 

    Since January 2024, FIIs have sold total equities worth Rs 77,597 crore. FII shareholding in Indian equities were at a 12-year low of 16% in January 2025.

    Speaking on the FII sell-off, Finance Minister Nirmala Sitharaman said, “FIIs go out when they are in a position to book profits. The Indian economy has an environment today where investments are yielding good results and profit-booking is happening.” 

    Sitharaman is dodging a bit here. Profit booking isn’t the only factor driving FIIs to sell. Concerns such as earnings downgrades, a weakening rupee, slower-than-expected GDP growth, and anemic private capital expenditure are also fueling the outflows.

    This Chart of the Week dives into the patterns of FII investments across various sectors in the past several months.

    FIIs trim holdings in Finance, Oil & Gas, and IT stocks 

    The financial sector bore the brunt of FII sell-offs in 2024 and January 2025. FIIs offloaded financial sector shares worth Rs 83,229 crore since January 2024, with January and October 2024 witnessing the highest outflows of Rs 30,013 crore and Rs 26,139 crore, respectively. 

    After four consecutive years of healthy double-digit growth, Indian equities faced earnings downgrades in the past two quarters. 

    The Indian government's estimates for GDP in FY25 confirmed the vibes – that the economy is seeing a slowdown. Real GDP growth is estimated to decelerate to 6.4% from 8.2% in FY24. This is below both the Ministry of Finance's forecast of 6.5% and the Reserve Bank of India's projection of 6.6%. 

    The Indian rupee also weakened to a record low of Rs 87.2 against the US dollar in January 2025, after the RBI stopped aggressively defending the rupee via dollar sales. This depreciation has increased currency risk for FIIs, potentially triggering further outflows as investors sought to limit foreign exchange losses. 

    Dr. V K Vijayakumar, Chief Investment Strategist at Geojit Financial Services, noted, "Despite the massive FPI selling in financials, this sector is resilient since the valuations are fair and every selling is being absorbed by Domestic Institutional Investors (DIIs) and individual investors, particularly HNIs." 

    The oil & gas sector also saw substantial FII exits, with total sell-offs amounting to Rs 57,912 crore by January 2025. Notably, October, November, and December 2024 alone accounted for Rs 45,616 crore of these outflows. 

    Fluctuating global oil prices from geopolitical tensions and supply-demand imbalances from US sanctions on Russian crude oil, have created uncertainty in the sector. FIIs further lost confidence in the sector due to domestic policy adjustments, including changes in subsidies and taxation.

    The oil & gas marketing industry’s revenue and net profit declined by 3.8% YoY and 65.8% YoY during Q3FY25, further contributing to the sell-off. With the sector weakening, BPCL fell out of the Nifty 50 index in the most recent reshuffle.

    The IT sector presents a mixed picture. While specific periods saw FII interest, the overall trend  indicates caution. In January 2025, FIIs withdrew approximately Rs 6,471 crore from IT stocks, reversing the Rs 14,566 crore invested in November and December 2024. Signs of a potential slowdown in key markets such as the US, have investors anticipating reduced demand for IT services.

    High valuations in the IT sector and earnings downgrades prompted FIIs to book profits. Aamar Deo Singh, Senior Vice President of equity, commodity, and currency at Angel One, referred to this as a "double whammy," as the dip in consumer sentiment follows higher-than-expected January inflation figures of 3% compared to 2.9% in December. 

    Consumer Services and Capital Goods sectors see limited FII interest

    FIIs showed mixed interest in sectors like consumer services and capital goods. While these sectors saw good FII activity, the investments were modest. The sectors saw FII investment in H1CY24. However, investor interest declined towards the end of 2024 and January 2025.  

    Despite the Union Budget's focus on boosting discretionary spending, concerns over stretched valuations and a slowing trend in urban consumption led to profit-booking by foreign investors. A continued recovery in demand is needed for investors to return.

    Healthcare and Realty sectors attract FIIs, backed by favourable government regulations

    As a defensive sector, the healthcare sector attracted FII investments with inflows of Rs 23,984 since January 2024. The sector also witnessed FIIs investing Rs 20,823 crore from June to September 2024 after expectations of increased spending. India's healthcare sector continued to expand, with growing demand for hospital chains, specialized treatments, and innovative drug research. Government initiatives to improve healthcare services made the sector attractive to foreign investors.

    The realty sector saw a surge in foreign institutional investments of Rs 5,375 crore, Rs 2,061 crore and Rs 4,778 crore in September, November, and December 2024. This suggests growing confidence in India's real estate market. Rapid urbanization and government initiatives aimed at infrastructure development have strengthened the realty sector's prospects. 

    Overall, 2024 witnessed significant FII outflows, with financials and oil & gas sectors facing the largest withdrawals. So far, 2025 has seen a similar trend. However, the healthcare and real estate sectors have attracted foreign investments – investors are lifting some boats over others

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    25 Feb 2025
    Five stocks to buy from analysts this week - February 25, 2025

    Five stocks to buy from analysts this week - February 25, 2025

    By Ruchir Sankhla

    1. Nazara Technologies:

    ICICI Securities maintains a ‘Buy’ rating on this internet software company with a target price of Rs 1,080. This indicates an upside potential of 16.9%. Analysts Abhisek Banerjee and Jayram Shetty highlight its strong growth potential, supported by recent acquisitions, business expansion, and a solid market position in gaming, eSports, and ad-tech.

    The company is expanding through acquisitions, including a 60% stake in indoor play center Funky Monkeys for Rs 43.7 crore, marking its entry into the physical entertainment gaming segment. It also acquired CATS: Crash Arena and King of Thieves from ZeptoLab for Rs 65.5 crore, strengthening its mobile gaming portfolio. Additionally, its eSports subsidiary, Nodwin Gaming, acquired esports events business StarLadder for Rs 46.8 crore, enhancing its global eSports leadership.

    Banerjee and Shetty note that the investor interest remains strong, with Axana Estates investing ~Rs 495 crore for a 5.4% stake, alongside a public offer for an additional 26%. Management targets Rs 300 crore EBITDA by FY27, driven by scaling up its content library and expanding partnerships with game developers and publishers.

    2. Marico:

    Sharekhan retains its ‘Buy’ rating on this consumer goods manufacturer with a target price of Rs 780, indicating a potential upside of 25.4%. The company’s Q3FY25 revenue rose 15.4% YoY to Rs 2,794 crore due to growth in core categories such as coconut oil, hair oils, and premium refined edible oils, along with contributions from new business expansion, while its net profit increased 4.2% YoY to Rs 399 crore.

    The analysts note that the domestic volume grew 6%, improving from 5% in Q2 and 4% in Q1. International sales rose 16%, driven by 20% growth in Bangladesh, 35% in the Middle East and North Africa, and 17% in South Africa. Operating profit rose, but operating margin fell 210 bps YoY to 19.1% due to higher copra and vegetable oil prices.

    The company’s management believes that the consistent growth in the core portfolio, driven by brands like Parachute and Saffola, and over 20% growth in the foods and premium personal care portfolio, led by Saffola Oats, True Elements, Plix and Beardo. Additionally, a double-digit growth in the international business will help revenue expansion in the medium term. Analysts are optimistic about the company and expect a CAGR of 11.9% in revenue and 15.1% in net profit over FY25-27.

    3. Federal Bank:

    Emkay retains its ‘Buy’ rating on this bank with a target price of Rs 240, indicating an upside potential of 34.3%. Analysts Anand Dama and Nikhil Vaishnav highlight the bank’s efforts under new MD & CEO KVS Manian to strengthen its core and become a top private bank.

    Dama and Vaishnav note that the bank has built a strong digital and physical network, a diverse loan portfolio, and stable leadership. The bank now aims to improve profitability with a return on assets (RoA) of 1.4-2.3% over the next 3-4 years and join top private banks like ICICI Bank and HDFC Bank. To achieve this, it is focusing on improving margins and asset quality.

    Recently, the bank has taken steps such as deliberately slowing growth to manage liquidity and asset quality risks, increasing provisions for bad loans, and shifting auto loans to fixed rates to handle interest rate changes better. It plans to improve its CASA (current and savings account) ratio to 36% from 30% by FY28 by expanding in Tier-2 cities, attracting non-resident deposits, and offering wealth management services. 

    4. Indus Towers:

    Ventura initiates coverage on this telecom infrastructure company with a ‘Buy’ rating and a target price of Rs 450. This indicates a potential upside of 35.7%. The company’s net profit surged 2.6X YoY to Rs 4,003 crore in Q3FY25. This increase was mainly after Indus reversed a Rs 3,020 crore provision (previously set aside for doubtful payments from Vodafone Idea), bringing the total pending amount down to Rs 500 crore. Additionally, the company raised Rs 1,910 crore in Q3 by selling a pledged 3% stake held by Vodafone PLC.

    The analysts highlight that 5G rollouts are driving demand for towers and co-locations. In Q3, Indus Towers added 4,985 macro towers and 7,583 co-locations. They note that growing 5G adoption will require more infrastructure to manage increasing traffic. Indus Towers is expanding its In-Building Solutions (IBS) portfolio, with small cell deployment in malls, airports, and stadiums to improve indoor coverage and network capacity.

    The analysts expect the company’s tenancy ratio (average tenants per tower) to increase from the current 1.65X to 1.7X by FY27.

    5. Ethos:

    Axis Securities maintains a ‘Buy’ rating on this specialty retail firm with a target price of Rs 3,070, indicating a potential upside of 20.7%. A retailer of luxury watches and accessories, Ethos added five new stores in Q3FY25, bringing the total count to 73. The company’s management stated that it remains committed to expansion and aims to open six more boutiques by the end of FY25.

    Ethos reported a 32% YoY revenue growth in Q3, reaching Rs 376 crore. EBITDA margins stood at 15.4%, down 42 bps, impacted by higher costs from hiring staff for new stores and rent for recently opened stores that are still in their early sales phase.

    Analysts Preeyam Tolia and Suhanee Shome project the company's revenue to grow at a 34.5% CAGR over FY25-27, driven by a higher share of high-margin exclusive brands and expansion into luxury segments like luggage and jewellery. The company’s management aims for 10x revenue growth over the next decade.

    Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

    (You can find all analyst picks here)

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    21 Feb 2025
    Five Interesting Stocks Today - February 21, 2025

    Five Interesting Stocks Today - February 21, 2025

    By Trendlyne Analysis

    1. Narayana Hrudayalaya:

    Thishealthcare facilities company surged 3.1% on February 18 following the announcement of itsQ3FY25 results. During the quarter, the company’s revenue rose 13.6% YoY to Rs 1,366.7 crore. Its net profit grew 2.6% YoY to Rs 192.9 crore, beating theForecaster estimates by 6.6%. 

    The growth was driven by better realizations, with an Average Revenue Per Occupied Bed (ARPOB)growth of 9% YoY, and increased domestic patient footfalls. However, international patient volumes declined by 51% YoY and 48% QoQ, primarilydue to a drop in patients from Bangladesh amid geopolitical issues.

    In Q3FY25, revenue from the Cayman Islandsrose 14% YoY, accounting for 21% of total sales. Growth was driven by strong outpatient demand at the new Camana Bay hospital. Inpatient department operations began in January 2025, with full operationalization expected by Q4FY25.

    Sandhya J, Group Chief Financial Officer of the companysaid, “We are entering a capex growth phase right now, and are going to add at least 1,400 beds in the next 3 to 4 years.” The company plans toexpand further, adding about 2,000 beds over six years.

    To support this expansion, the company has allocated acapex of Rs 1,650 crore in FY25, Rs 1,000 crore in FY26, and Rs 850 crore in FY27. Key projects driving this expansion include new hospitals in Bangalore and Kolkata, a 300-bed expansion in Raipur, and a 220-bed facility in Central Bangalore. Additionally, the company isexploring expansion opportunities in existing locations and aims for returns of over 15%. 

    Post results, Prabhudas Lilladhermaintained its ‘Buy’ rating on the company, citing its aggressive expansion plans and strong financial performance, including a 10% YoY increase in EBITDA and 9% YoY ARPOB growth in India. The brokerage also highlights operational efficiencies, improved margins in new India units, and the anticipated ramp-up of the Cayman unit as key factors supporting its recommendation, with a target price of Rs 1,560.

    2. Muthoot Finance:

    This gold loan NBFC surged by 6.2% on February 13 following the announcement of its Q3FY25 results. Muthoot Finance’s net profit increased 25.9% YoY to Rs 1,389.2 crore, beating Trendlyne’s Forecaster estimates by 4.4%. Revenue grew 35.9% YoY to Rs 5,189.7 crore during the quarter. 

    During the quarter, the company reported its highest-ever AUM growth of 34% YoY at Rs 1.1 lakh crore. The gold loan segment witnessed remarkable growth of 34% YoY, compared to Q2FY25 (up 28% YoY), driven by higher gold prices and new customer additions. Commenting on this, George Alexander Muthoot, the Managing Director, said, “There is strong demand for gold loans as credit from other sources, including fintech, unsecured, and microfinance lending, has dried up in recent months". 

    Muthoot Finance witnessed a drop in its microfinance (MFI) lending in Q3. The company’s disbursals were down 47% YoY as it remained cautious, given sector challenges. The MFI sector has been facing pressures due to rising bad loans and slower growth. Muthoot’s GNPA (gross non-performing asset) in the microfinance business rose to 2.9% from 1.9% in Q3FY24. However, conditions are expected to improve over the next few quarters as the company moves its focus to improving its collection efficiency as well as the quality of its loan book.

    Going forward, the management maintains its guidance for gold loan growth at 25% YoY in FY25. For FY26, Muthoot Finance projects a 15% growth and expects to surpass the target. 

    Following the company’s earnings announcement, Nuvama upgraded its rating to ‘Buy’ from ‘Reduce’ and raised the target price to Rs 2,550. The brokerage believes the company is well-positioned for sustained growth. It remains bullish due to Muthoot Finance’s consistent performance, supported by rising gold prices. Trendlyne classifies it as a Turnaround Potential stock.

    3. ITC:

    This cigarettes & tobacco products company touched a 52-week low of Rs 396.2 on 20th February. The decline in its stock price came after reports suggested that the government may increase the GST on tobacco products once the compensation cess is removed. Currently, cigarettes and other tobacco products are subject to a 28% GST, along with cess and other levies, bringing the total indirect tax to 53%.

    The government aims to maintain its tax revenue from tobacco products after the compensation cess ends on March 31, 2026, and is not inclined to replace it with another cess. The GST Council's Group of Ministers (GoM) had previously suggested linking the cess to a product’s maximum retail price instead of its sales value. This proposal was later referred back to the fitment committee and the GoM on rate rationalization.

    On February 8, ITC announced its plan to enter the frozen foods and ready-to-cook business by acquiring a 43.8% stake in both ‘Prasuma’ & ‘Meatigo’ for around Rs 300 crore, reportedly. The deal is expected to be completed in over three years. ITC plans to increase its stake to 62.5% in ‘Prasuma’ by April 2027, with the remaining stake to be potentially acquired by June 2028. Hemant Malik, Wholetime Director of ITC, stated, “The deal will enable ITC to develop a portfolio in the frozen, chilled, and ready-to-cook (RTC) segment of the Rs 10,000 crore market, which holds significant growth potential.”

    The Company announced its Q3FY25 results on February 6th. During the quarter, its net profit declined by 7.5% YoY to Rs 4,934.8 crore due to muted demand in FMCG and hikes in prices of key input materials like edible oil, leaf tobacco and wood. Revenue was up by 8.6% YoY. The company’s revenue beat forecaster estimates by 6.9%, due to growth in the cigarettes and agri segment revenue. It appears on a screener for stocks with high FII stock holdings.

    KR Choksey has maintained a ‘Buy’ rating on ITC but lowered its FY26 and FY27 EPS estimates by 6.1% and 7.5%, respectively, due to the hotel business demerger, weak Q3FY25 performance, soft demand, and inflationary pressures. Despite this, the brokerage remains optimistic about ITC’s long-term prospects, thanks to its strong cigarette market share, solid FMCG execution, and rural demand recovery. Following the demerger, the brokerage has adjusted its valuation to 40% of market capitalization with a 20% holding discount, lowering its target price to Rs 494.

    4. ABB India:

    This heavy electrical equipment company has fallen by 2.8% over the past week, despite surpassing the Forecaster estimates for revenue and net profit in its Q4CY24 results. The company's order inflow (OI) declined 14% YoY to Rs 2,700 crore, primarily due to a 30% drop in the motion (motors and drives) segment. This segment benefited from a large data centre order in Q4CY23. However, base orders (with completion timelines of 3-12 months) rose 4%, while the order book stood at Rs 9,400 crore.

    CFO T. Sridhar said, "The market is easing out, which can lead to lower pricing power on new orders.” Sridhar flagged profit margin pressures, “We expect profit margins to settle in the 12-15% range (15.4% in CY24)," he said. 

    Sridhar noted that while order growth was strong earlier, sustaining the same pace may be difficult since the company already has a large number of existing orders. However, he expects private capex to rise after the 2025 budget, with growth driven by sectors like power generation, automotive, food & beverages and data centres.

    ABB India’s EBITDA margin improved to 19.5% (up 440 bps) due to high-margin orders and better capacity utilization. The company appears in a screener of stocks with growing costs YoY from long-term projects.

    ABB’s MD, Sanjeev Sharma, discussed the impact of US tariffs, stating that they could open opportunities for India to expand its role in global trade. While the company has grown its export portfolio, it still accounts for only 10% of its business. The company anticipates exports to contribute positively to India, despite global market fluctuations.

    Post results, ICICI Securities upgraded its rating on ABB India to ‘Hold’ with a target price of Rs 5,302. The brokerage believes the company will benefit from the Centre's capex push in renewables, infrastructure, EVs, and manufacturing. Additionally, its strong distribution network enhances its ability to secure industry orders.

    5. Cipla:

    This pharmaceuticals company has risen 2.1% in the past month in a weak market owing to strong Q3FY25 results, where revenue and net profit grew by 7.5% YoY to Rs 7,294.6 crore and 48.7% YoY to 1,570.5 crore. 

    On Wednesday, the company invested ZAR 900 million (~Rs 424.9 crore) in its subsidiary, Cipla Medpro South Africa Proprietary, for 4.1 crore shares. The company has a strong presence in South Africa and intends to expand its footprint. 

    The drug maker also received final approval from the US FDA for a new drug application (NDA) for Nilotinib Capsules and a Form 483 with two observations from the US FDA following a good manufacturing practices (GMP) inspection at its analytical testing facility in Navi Mumbai. 

    The company’s Q3 revenue and net profit beat Forecaster estimates by 1.9% and 30.4%, respectively. Revenue improved due to increased sales in the Indian, South African, and rest of the world (RoW) markets. However, the US market witnessed a downturn due to Lanreotide supply issues due to temporary lower production at a partner facility. 

    The company’s Indian business grew due to improvements in branded prescriptions, chronic, and trade generics. Meanwhile, reducing inventory and finance costs, combined with launching high-margin products, helped its net profit grow. 

    Speaking on its results, Cipla’s MD and CEO, Umang Vohra, said, “Our Emerging Markets & Europe (EMEU) and One Africa businesses together account for more than 25% of total revenue, similar in size to our US business. In 9MFY25, these markets combined have delivered a strong growth of 15% YoY. Our diversification and backlog of our launch pipeline gives us confidence in a resilient business model.”

    Post results, Axis Direct retains its ‘Buy’ call on Cipla. It has a target price of Rs 1,700 per share, indicating a potential upside of 15.2%. The brokerage believes that the company’s India business will continue to grow, driven by diversification and a strong launch pipeline. However, it expects the US business to remain sluggish due to the continued supply issues of Lanreotide. Axis Direct expects the firm’s revenue to grow at a CAGR of 8.3% over FY25-26.

    Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    20 Feb 2025

    Chart of the Week: US import tariffs trigger a trade war

    By Abdullah Shah

    With US President Donald Trump imposing retaliatory import tariffs and threatening even more (“It’ll be 25% and higher, and it’ll go very substantially higher over a course of a year”)the world is facing a trade war. Global markets have turned volatile and India’s Nifty 50 index has fallen 1.2% over the past month. 

    The ordeal started with President Trump issuing three executive orders on February 1 to impose import tariffs on China, Canada, and Mexico. The US levied a 10% import tariff on all Chinese goods and a 25% duty on imports from Mexico and Canada, effective February 4. However, President Trump delayed the duties on Mexico and Canada for 30 days after reaching deals with them. Trump followed this by imposing another 25% import duty on all steel and aluminium imports, including Canada and Mexico, effective March 12. The duty will also include finished metal products. 

    President Trump has indicated further retaliatory tariffs of 25% on imports of automobiles, expected to be rolled out in April 2025 after saying that the EU and India have  unfair taxes on US automobile exports. Trump is also planning  additional 25% import duty on the pharmaceuticals and semiconductor sectors to promote domestic factories in the US. 

    With reciprocal tariffs dominating headlines, we look at the countries with the highest tariffs on imports from the US in this chart of the week.

    The European Union and India give contrasting responses to the tariffs

    In the Union Budget FY26 meeting, India reduced its average import tariff to 10.7% from 11.7% in response to the US's threat of tariffs on pharmaceutical and automotive products. India has reduced customs duties on bourbon whiskey by 50 percentage points to 100% and levies on high-end motorcycles by 20 percentage points to 30%. 

    A report by Nomura suggests that even with increased US tariffs from 15-20%, the decline in Indian exports to the US would be approximately 3% to 3.5%. The relatively minor fall is attributed to India's efforts to diversify its export markets, enhance value addition, and develop alternative trade routes. S&P Global Ratings also believes India's economy is more oriented towards domestic products and less reliant on exports, further lowering the effects of tariffs.

    The 25% tariffs by the US on steel and aluminium imports will also apply to the European Union (EU) despite the EU signing a free trade agreement with the Biden administration. This is despite European countries like Germany, Ireland, Italy, and France having low import tariffs on US goods due to the US importing a large number of goods from the region. Ireland has an average tariff of 6.5%, while Italy, Germany and France have an import tariff of 2% each. 

    European Commission President Ursula von der Leyen said that the EU will take proportionate countermeasures to protect its interests. EU Trade Commissioner Maroš Šefcovic emphasised the potential for these tariffs to fuel inflation and disrupt global trade. The EU is considering various retaliatory measures, including tariffs on iconic American products and potential legal challenges through the World Trade Organization (WTO).

    These steel and aluminium tariffs, revoking previous agreements that had allowed tariff-free quotas for UK steel exports, also impact the country’s steel industry. These free trade agreements helped the US with lower import tariffs of 3.8% for US goods in the UK. However, the US is the UK's second-largest steel export market, with approximately 2 lakh tonnes of steel, valued at over £400 million, exported annually. The reintroduction of these tariffs will promote domestic steel production in the US but poses a substantial threat to the UK's steel industry, potentially leading to decreased exports and financial losses. 

    China and Canada respond to the US tariffs

    After Trump announced the tariffs, Canada responded on February 3 with President Justin Trudeau imposing a 25% duty on imports of all US goods. This was followed by Mexico’s President Claudia Sheinbaum taking tariff and non-tariff measures in defense of Mexico’s interests. 

    The moves prompted President Trump to hold talks with the two countries and delay the implementation of the tariffs on Mexico and Canada by 30 days. 

    The tariffs will put pressure on consumer prices, contributing to inflation in the US. Federal Reserve officials have expressed concerns that these trade policies could disrupt supply chains and increase costs for businesses and consumers. 

    Speaking on the tariffs on Mexico and Canada, the US National Association of Manufacturers President and CEO Jay Timmons said, “A 25% tariff on Canada and Mexico threatens to destroy the very supply chains that have made US manufacturing more competitive globally. Manufacturers will bear the brunt of these tariffs, undermining our ability to sell our products competitively and putting American jobs at risk.”

    In response to the US levies, the Chinese Finance Ministry announced a 15% tariff on coal and liquefied natural gas and 10% on crude oil, farm equipment, large-displacement vehicles and pickup trucks from the US. While announcing the tariffs, the Finance Ministry stated, “The unilateral imposition of tariffs by the US seriously violates the rules of the World Trade Organization. It is not only unhelpful in solving its own problems but also damages economic and trade cooperation between China and the US.”

    China has also applied export restrictions on critical minerals, such as tungsten, tellurium, ruthenium, molybdenum, and ruthenium-related items.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    20 Feb 2025
    How pessimistic are Indian CEOs after a weak Q3? | Screener: Multibagger stocks that are beating the bears

    How pessimistic are Indian CEOs after a weak Q3? | Screener: Multibagger stocks that are beating the bears

    When it comes to growth predictions, the biggest optimist in the mix is not the investor or the analyst, but the company management. The CEO rides or dies on the basis of how their company performs. So they can't help wearing rose-colored glasses.

    But the Q3 results came out in a pretty bearish market, and have disappointed. Nearly half of the companies announced negative or neutral profit growth. Average revenue growth across the universe is in the low single digits. It's hard to be cheerful in the face of these numbers. 

    We take a closer look at what the management focused on, in this results season's earnings calls. CEOs are battling weak domestic demand, rising trade barriers from a confrontational Trump White House, and a slowing global economy. A rising dollar - as Trump keeps talking up reciprocal tariffs - is not helping.  

    In this week's Analyticks:

    • Mood Tracker: What are the risks and opportunities CEOs are talking about in earnings calls?
    • Screener: Multibagger stocks that are still beating the bear market

    Let's take the temperature.


    It's hot under the collar: CEOs discuss their biggest risks

    The problem? CEOs talk a lot. The solution? Trendlyne's Discover, which allowed me to search for specific comments and phrases across all earnings calls. This tool saved me a lot of time this week. I didn't have to wade through every line of each earnings call, while my eyesight suffered, my family fell apart and my cat escaped. Instead, my cat is happily sunbathing (proof) while I bring you this data.

    When we look at CEO commentary across earnings calls, management is pointing to a challenging economic environment.  

    Nikhil Sohoni, CFO at Blue Star, noted that margins have been impacted across key segments, and "we expect the revival to happen only slowly, over the next year." Some industries like cement saw temporary regional weaknesses, like in South India, where prices were depressed since price revisions happen in December. But in most industries, the twin problems of low demand and rising costs are not expected to resolve by Q4. 

    The twin monsters of Trump tariffs and inflation

    The new US administration has  arrived with the intention to shake things up. President Trump is firing federal workers, letting Elon Musk comb through government databases, and threatening tariffs against major trade partners.

    Joe Biden rarely got a mention from Indian CEOs. But Donald Trump looms large in the discussions, especially with major export players, from electronics to auto. 

    For CEOs, a worry that comes from Trump tariffs is trouble closing deals. Trump has been making threats with long timelines, where tariffs get imposed in March or April this year. K Natarajan, MD of Galaxy Surfactants, noted that some deal talks have frozen in place as a result, with customers saying that they "want to wait and watch" to see what kind of tariffs get implemented.

    The other challenge is in having to realign supply chains. CEOs note that while tariffs will be passed on to customers, companies will have to work to minimize their effects over time. "For the short term, Trump tariffs will have to be passed on to the market," Nikhil Kumar, MD of TD Power says. "In the longer term, we will have to see where we can manufacture where the duties will not apply." 

    Other threats, like inflation and rising debt, were mainly raised by CEOs in response to questions from analysts. Many are counting on inflation and interest rates coming down over the next few quarters, making these less of a threat compared to a trade war.

    CEO commentary suggests that most think that the worst is behind them. Analysts may discount such optimism, but the management is pointing to lower inflation, and indicators showing recovering manufacturing and services activity. Companies are also responding with new product and capacity investments.

    Some industries are also benefiting from growing export markets, despite the broader headwinds. GE Vernova T&D has for instance, seen a rise in large deals from Europe in the energy and utilities sector, as energy transition investments in the EU ramp up.  

    The biggest opportunities in specific industries are getting mentions from multiple CEOs. GLP - weight loss drugs - is one of the biggest, with a stream of generic drugs coming in from Indian pharma as patents start to expire in 2026 in Asia and Africa. The electric vehicles ecosystem has also been a strong deals pipeline for auto and auto component manufacturers, even as tariffs loom.

    But while areas like defence spending still remain high and lucrative, opportunities like large infrastructure projects may be slowing down. "NHAI projects have become competitively very crowded", the MD of Afcons Infrastructure says, "So we are mainly looking into state level proposals now."

    CEOs are hoping that the tax cuts from the Budget will boost domestic demand, and the new RBI leadership will drive interest rate cuts. But for management, uncertainty is the real growth killer. Tariffs now are better than the promise of tariffs later, since the second freezes companies and customers in place. Once the US administration finally drops the hammer, Indian CEOs can make their moves. 


    Screener: Multibagger stocks which are rising in the past quarter

    Beating the bears: Pharma, metals stocks are among the big gainers

    The Indian equity markets have seen a massive sell-off of Rs 63,641.1 crore by foreign investors over the past month after threats of import tariffs from President Donald Trump, resulting in the Nifty 50 falling by 1.5%. In this volatile market, we look at multibagger stocks which have continued their share price growth. This screener shows multibagger stocks rising in the past quarter despite a negative sentiment in the market.

    The screener is dominated by stocks from the pharmaceuticals & biotechnology, general industrials, banking & finance, food, beverages & tobacco, and consumer durables sectors. Most notable stocks in the screener are PG Electroplast, Shakti Pumps (India), Wockhardt, Godfrey Phillips India, BSE, Blue Jet Healthcare, Sarda Energy & Minerals, and Lloyds Metals & Energy. 

    PG Electroplast features in the screener after rising 318.5% in the past year. This consumer electronics company has continued this trend in recent months, rising 24.5% in the past quarter after posting positive results in Q3FY25. Its revenue and net profit grew by 81.6% YoY to Rs 974.9 crore and 106.2% YoY to Rs 39.5 crore, respectively. 

    Higher sales of air conditioners and washing machines contributed to revenue growth. The company’s stock price also surged after signing an agreement with Whirlpool of India on December 24, 2024. PG Electroplast will manufacture some of the stock-keeping units (SKUs) for semi-automatic watching machines for Whirlpool at its facility in Roorkee. 

    Shakti Pumps has risen 189.5% in the last year. This industrial machinery company’s stock price increased by 11.3% in the past quarter, driven by strong Q3FY25 results. Its revenue grew by 31.3% YoY to Rs 652.7 crore on the back of an improvement in sales in the domestic market. On the other hand, net profit increased by 130.2% YoY to Rs 104.1 crore, owing to deferred tax returns during the quarter. 

    The company’s stock price also got a boost after it entered a partnership with ReNew Photovoltaic on February 3 to supply a domestic content requirement (DCR) cell-based solar module worth Rs 1,300 crore. Its board of directors also approved raising Rs 400 crore by issuing equity shares through a qualified institutional placement (QIP) in January.

    You can find some popular screeners here.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    18 Feb 2025
    Five stocks to buy from analysts this week - February 18, 2025

    Five stocks to buy from analysts this week - February 18, 2025

    By Divyansh Pokharna

    1. United Breweries:

    Anand Rathi maintains its ‘Buy’ rating on this breweries & distilleries company with a target price of Rs 2,610, indicating a potential upside of 29%. Telangana recently announced a 15% price hike on beer, following a pause in supply from UB. The company had suspended supplies to Telangana Beverages Corp due to losses from unchanged base prices for two years. The state's price hike now enables the company to resume sales with better margins.

    United Breweries holds a 70% market share in Telangana's beer market, contributing around 15% to its revenue. Analyst Ajay Thakur expects a 2% rise in revenue and a 200 bps improvement in margins due to this price hike.

    United Breweries is focusing on cost-saving initiatives, some of which will incur upfront costs in FY25. Thakur highlights that these efforts are expected to result in annual fixed cost savings of 1.5–3%. Thakur projects a 380 bps expansion in EBITDA margin from these.

    Thakur also expects a strong start to seasonal sales, as reports suggest a hot summer. He said, “Last year, multiple election phases negatively impacted the sales of beer and alcoholic beverages, but this won’t be the case this time, allowing for better capture of seasonal demand.” He has factored in an 11.5% revenue CAGR over FY25-27.

    2. Fortis Healthcare:

    Prabhudas Lilladhar maintains a ‘Buy’ rating on this healthcare facilities company with a target price of Rs 760, indicating an upside potential of 25.8%. The company’s Q3FY25 net profit rose 84.1% YoY to Rs 247.9 crore, aided by a Rs 23.5 crore exceptional gain from the sale of its Richmond Road facility in Bangalore in December 2024. Revenue increased 14.8% YoY to Rs 1,928.3 crore.

    Analysts Param Desai and Sanketa Kohale highlight that the hospital business revenue grew 17% YoY to Rs 1,620 crore, supported by higher occupancy and an improved average revenue per occupied bed (ARPOB). Occupancy rose to 67% from 64% in Q3FY24, while ARPOB increased 10% YoY to Rs 67,100, driven by a favorable case mix and price revisions in February 2024.

    The analysts note that the company plans to add 400 brownfield beds at Fortis Memorial Research Institute, Faridabad, and Noida by FY26. Of its 350 planned greenfield beds in Manesar, 50 are operational, with another 50 expected by March 2025. Management targets 350-400 brownfield bed additions annually for two years. Desai and Kohale expect a CAGR of 13.2% in sales, 19.7% in EBITDA, and 21.7% in net profit over FY25-27.

    3. Eicher Motors:

    Emkay maintains a ‘Buy’ rating on this motorcycle manufacturer with a target price of Rs 6,100. This indicates an upside potential of 29.3%. Eicher Motors’ Q3FY25 net profit grew 17.5% YoY to Rs 1,170.5 crore. Revenue increased 18.7% YoY to Rs 5,261.9 crore, helped by higher two-wheeler and commercial vehicle sales.

    Analysts Chirag Jain, Jaimin Desai and others note the company achieved 17% volume growth in Q3FY25, outperforming the industry, thanks to new product launches like the Battalion Black Edition of the Classic 350 and Hunter 350. Royal Enfield’s domestic motorcycle market share increased to 8%, a 1.1% YoY rise. Eicher Motors also increased brand awareness with targeted marketing spends (~Rs 70 crore), which helped drive demand.

    The analysts highlight that the company expects to reduce discounts and increase prices due to new emission rules (OBD2 Phase B), which require higher manufacturing costs. With strong government capex support, the company is on track to meet its FY25 capex target of Rs 1,000 crore. They expect a CAGR growth of 12.8% in revenue, 13.9% in net profit, and 8.9% in Royal Enfield volumes over FY25-27.

    4. Va Tech Wabag:

    Axis Direct maintains a ‘Buy’ rating on this non-electrical utilities firm with a target price of Rs 1,970. This indicates a potential upside of 51.7%. The company has secured new orders worth over Rs 2,781 crore in Q3FY25, taking its total order book to around Rs 14,200 crore. It also recently won a Rs 3,251 crore consortium order for the Al Haer Independent Sewage Treatment Plant in Saudi Arabia. Analysts Sani Vishe and Shivani More expect the company to surpass its Rs 16,000 crore order book target by the end of FY25.

    The company reported a 15% YoY growth in revenue to Rs 811 crore in Q3. EBITDA margin stood at 12.4%. The company’s management noted that margins were lower during the quarter due to project-specific variations, but expects improvement in the medium term. EBITDA margins are projected to be in the 13-15% range, possibly exceeding the upper limit. They are confident of a stronger performance in Q4, as it is typically the best quarter of the year in terms of performance.

    Vishe and More are upbeat about Va Tech's focus on expanding its share of higher-margin international, industrial, and operations and maintenance (O&M) contracts. They believe the company's strong order book, which provides revenue visibility for the next 3-4 years, particularly from international projects, will help it achieve its targeted margins.

    5. EPL:

    Motilal Oswal reiterates its ‘Buy’ rating on this packaging firm with a target price of Rs 300. This indicates a potential upside of 20.8%. In Q3FY25, the company’s revenue grew 4% YoY to Rs 1,010 crore. EBITDA margin increased by 107 bps to 19.9%, helped by better margins in the Americas and Europe. The company’s management expects these strong margins to continue, supported by demand in Brazil, which is prompting the company to accelerate its capacity expansion in the region.

    Analysts Sumant Kumar, Meet Jain, and Nirvik Saini noted that potential tariffs do not impact the company’s US operations as it manufactures locally and sources laminates from India. If China faces trade restrictions, EPL could gain market share. Additionally, EPL is establishing a beauty & cosmetics manufacturing facility in Thailand to improve delivery speed and localization. The company is targeting a market of 150 crore units annually and plans to expand into Indonesia, Vietnam, and Malaysia.

    The company’s Q3 financials were impacted by currency devaluation in Brazil and Egypt. However, the management expects forex fluctuations to balance out over time, and anticipates some reversal of forex losses in Q4.

    Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

    (You can find all analyst picks here)

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    14 Feb 2025, 05:28PM
    Five Interesting Stocks Today - February 14, 2025

    Five Interesting Stocks Today - February 14, 2025

    By Trendlyne Analysis

    1. SBI Cards and Payment Services:

    This finance company rose by over 5% on 13th January and touched a 52-week high of Rs 872 today. The surge in its stock price came after the global brokerage Macquarie upgraded its rating on the stock to ‘Outperform’, as it believes that the company's credit card delinquencies have decreased, indicating better lending choices. Over the past 12 months, the company limited credit to borrowers with higher credit scores. The brokerage has also increased the stock's target price to Rs 1,000.

    Its Q3FY25 net profit declined by 30.2% YoY to Rs 383.2 crore due to tighter regulations on fee income. Revenue was up by 0.5% YoY, primarily due to marginal growth in interest income. The company’s net profit missed forecaster estimates by 8.7%, due to a slower loan growth. It appears on screener for stocks where FIIs & FPIs are increasing their shareholding.

    The company’s Gross Non-Performing Assets (GNPA) slightly decreased to 3.24% during the quarter, down from 3.27% in the previous quarter. However, the gross credit cost rose by 40 bps to 9.4% QoQ. 

    Regarding the increase in credit costs, the company’s CEO & MD, Abhijit Chakravorty, said, “We are at an inflection point in our credit cycle. As we tighten underwriting, portfolio management, and collections, we expect credit costs to moderate. The speed of this will depend on changes in the unsecured lending ecosystem and the economy.”

    According to RBI’s December 2024 data, the company's market share in card spends stood at 15.6%. Girish Budhiraja, Chief Sales & Marketing Officer, stated, "We expect our card spend market share to reach 18-20% in the next 3-4 quarters. We are projecting loan growth of 12-15% over the next 9-12 months. However, our outlook could change in either direction if the credit cost trajectory shifts or the economic mood changes."

    Macquarie forecasts a significant decline in the company’s credit costs over the next two quarters, driven by factors like falling interest rates, better liquidity, and potential tax cuts. The brokerage also points out that the RBI's more lenient approach to unsecured loans could be an added boost. However, it has reduced its earnings projections for FY25-27 by 13-15%, reflecting slower growth in loans, net interest income and fee generation. 

    2. National Aluminium Company:

    This aluminum manufacturer has fallen 7.8% in the past week despite beating Forecaster estimates for revenue and net profit in its Q3FY25 results. The decline comes after US President Trump’s move to set a 25% tariff on steel and aluminum imports without any exemptions. National Aluminium Co’s (NALCO) management noted that these tariffs could put pressure on global aluminum prices, similar to the impact seen in 2018-2020 after similar trade policies during Trump’s first term.

    NALCO announced its Q3FY25 results on February 10, reporting a 39% YoY increase in revenue to Rs 4,662 crore, driven by higher sales realisation in alumina and metal. Net profit surged 2.3X YoY to Rs 1,566 crore, thanks to lower employee benefit expenses, material costs, and finance costs. The company appears in a screener of stocks with book value per share improving over the last two years.

    Chairman & MD Pratap Singh said, “The alumina price trend of $400/tonne in previous years was breached when prices shot up to $800/t in Q3FY25 due to plant shutdowns in Australia. The prices are now correcting, with spot prices falling to $530/t and possibly declining further to the $450-500/t range.” 

    Singh also highlighted that analysts should not get too optimistic about the net profit jump – the decline in employee costs that drove profit higher, he noted, was due to a one-time provision for non-executive performance-related pay (PRP). Going forward, annual employee expenses are expected to stay over Rs 2,000 crore.

    Speaking about capex, Singh said that NALCO is expanding its alumina refinery, increasing capacity by 1 million tonnes per annum (MTPA) from the current 2.1 MTPA. The total capex for this expansion is now Rs 5,677 crore, of which Rs 3,500 crore has already been spent. The refinery is expected to be commissioned by the end of FY26, revised from the earlier target of September 2025.

    Axis Direct has a ‘Buy’ rating on this PSU stock with a target price of Rs 220. The brokerage expects strong alumina realisations to drive another good quarter in Q4FY25. However, with spot prices declining, the impact of lower alumina prices may be seen from Q1FY26 onwards. Additional alumina volumes from the ongoing refinery expansion, however, will help offset some of the impact of lower prices on EBITDA in the future.

    3. FSN E-Commerce Ventures (Nykaa):

    This internet retail company has declined 3% over the past week following the announcement of its Q3FY25 results. Nykaa’s net profit increased 61.4% YoY to Rs 26.1 crore, but missed Forecaster estimates by 29.6%. 

    Revenue rose 26.7% YoY to Rs 2,267.2 crore during the quarter, driven by growth in the beauty & personal care (BPC) and fashion segments. The company’s revenue beat estimates marginally by 0.2%.

    During the quarter, Nykaa’s GMV (gross merchandise value) grew 25% YoY, driven by strong growth in the BPC segment, which contributes the majority of its revenue and has seen an increasing customer base and festive demand. Meanwhile, Nykaa Cosmetics, Kay Beauty, and Dot & Key continued to drive growth with new launches – the company is pushing its own brands hard, including its wakeup makeup line. The fashion segment grew 8% YoY despite a challenging demand environment and intense competition.

    Recently, Shein, the Chinese low-cost fast-fashion giant, re-entered India through a partnership with Reliance Retail. Falguni Nayar, the CEO, underplayed the threat to Nykaa’s market share, saying, “Fashion is a vast industry. Shein operates in just one segment. With 4,000+ brands and more international players entering the market, no single brand can dominate”. 

    But analysts think differently, and believe Shein's re-entry into India could disrupt the country’s fashion market. Nykaa’s fashion vertical, which competes with Myntra, Tata Cliq Fashion, and Ajio, is expected to expand its catalogue with new brand partnerships. 

    Meanwhile, Nykaa continued to expand its retail network, with total stores reaching 221. The company expects to grow its store count to 350 over the next two years. 

    Following the Nykaa’s earnings announcement, Nuvama maintained its ‘Buy’ rating. The brokerage highlights that competition in fashion remains a concern, but profitability improvements in the eB2B segment are encouraging. It expects Nykaa’s beauty segment to remain a key growth driver.

    4. Global Health (Medanta):

    Thishealthcare facilities company surged 10.7% on February 5 following the announcement of itsQ3FY25 results. During the quarter, the company’s net profit rose 15.6% YoY to Rs 142.9 crore in Q3FY25, while revenue grew 13.3% YoY to Rs 943.4 crore. The growth was driven by higher patient volumes, with a 10% increase in footfalls and a 13% rise in In-Patient Department (IPD) admissions.

    The companyreported an Average Revenue Per Occupied Bed (ARPOB) of Rs 61,307, reflecting a marginal 1.2% YoY increase but a 1.3% QoQ decline. Toimprove ARPOB, Medanta is pushing high-value procedures, which contribute to better revenue per patient. 

    Medanta is also improving its payer mix by reducing dependence on lower-paying government schemes and increasing the proportion of insurance and cash patients. Additionally, the companyplans selective tariff hikes, particularly in facilities like Lucknow and Patna, where prices have remained unchanged for several years.

    In Q3 FY25, Medantaadded 34 beds, bringing the total bed additions to 219 for the first nine months of FY25. This has increased the company’s total operational bed capacity to 3,042. The company hassecured a long-term lease for a 110-bed hospital in Ranchi to expand its presence in Jharkhand. Additionally, the 550-bed Noida hospital is set to begin operations within six months. 

    Pankaj Sahni, Group Chief Executive Officer of the companysaid, “We have roughly 1,000 bed additions planned over the next two years. We also have 3 major Greenfield projects underway, comprising approximately 1,600 beds.” These include projects in Mumbai Oshiwara, Pitampura, and Greater Kailash, which are expected to be completed in the next 3 to 4 years.

    Post results, Axis Directmaintains its ‘Buy’ rating on this company, citing optimism about the business recovery, improvements in ARPOB, and capacity expansion. The brokerage expects a CAGR of 21.5% in sales, 18.2% in EBITDA and 18.1% in net profit over FY25-26, with a target price of Rs 1,270 per share.

    5. Power Finance Corporation:

    This financial institution is a value stock, under radar, according to Trendlyne’s DVM score. PFC exhibits high financial strength and is trading at an affordable valuation, demonstrated by its high durability and valuation scores. However, the stock price momentum is weak due to the recent correction in the stock market. Shares of PFC currently trade at a discount of over 35% from its 52-week high.

    In Q3, the company reported a revenue growth of 14% and a net profit growth of 23% on a YoY basis. Its consolidated loan book witnessed a 12% YoY growth, driven by disbursements in the renewable and distribution segments. To further expand its renewable portfolio, it entered into an agreement on January 16 with Japan Bank for International Cooperation for a loan of ~Rs 6,500 crore.

    Foreign currency borrowing makes up 19% of its total borrowings, of which 95% is hedged against currency fluctuations. The remaining 5% unhedged portfolio has come under risk following the recent depreciation of INR. Chairman and MD Parminder Chopra noted that PFC anticipates a loss of Rs 45 crore for every one-rupee depreciation of INR with respect to USD.

    PFC is in the advanced stages of resolving loan defaults totalling around Rs 5,000 crore from the KSK Mahanadi, TRN Energy, and Shiga Energy projects. Once resolved, it expects to release approximately 73% of the allocated provisions—roughly Rs 3,650 crore—which is the capital set aside to cover potential losses should these companies default on their loans.

    During the Q3 earnings call, Chopra said, “We expect these provision reversals to provide sufficient cushion against the impact of rupee depreciation.” The resolution of these defaults is expected to improve PFC’s asset quality, potentially lowering its gross non-performing assets (NPAs) from 2.7% at the end of Q3 to below 2%. 

    Chopra is confident of a strong performance in Q4, driven by disbursements in the renewable portfolio, which will help PFC achieve its guidance of 13-14% annual growth in assets under management for FY25. Motilal Oswal maintains a ‘Buy’ rating on the stock, anticipating a surge in disbursements of 110% YoY in Q4, supported by benign credit costs and the resolution of its stressed assets.

    Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.

    Copy LinkShare onShare on Share on Share on
     
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd